The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the efficacy of Retrovir (AZT) therapy in the treatment of HIV Ab positive persons
with impairments in neuropsychological functioning. To assess the safety, virologic, and
immunologic effects of AZT therapy in HIV Ab positive persons with neuropsychological
impairment but minimal other symptomatology.